Sun Pharma has snapped up Ocular Technologies from Auven Therapeutics, adding to its growing eyecare medicines pipeline.
Piramal added to its run of healthcare acquisitions with a $175 million deal to buy five injectable pain drugs from Johnson & Johnson.
Most pharmaceutical companies work with an average of seven bioanalytical labs in a given year, taking time and scientists away from important research and…
More than two years after buying Merck's OTC unit and local player Dihon, bringing together three separate consumer care businesses in China remains a…
Vietnam has been one of the fastest-growing economies in Asia in recent years, and Sanofi has just cut a deal to give it a stronger position in the market.
With Mitsubishi Tanabe deal, Sun Pharma takes a basket of new meds into Japan, a market where Indian drugmakers are under-represented.
"Binding" $1 billion offers are said to be on the table as Indian drugmakers Aurobindo and Intas go head-to-head for Teva's generics business in…
Chairman Zhou Jie resigns just three months after taking on the role.
By selling its Wako chemicals unit, the top Japanese drugmaker Takeda could raise $1 billion for reinvestment in its pipeline.
Rumors of Merck brand sale in India raise questions about the future of its generic drug division.
Sanofi provided insight into the logistics hurdles faced by vaccine makers in China after a distribution and sales rule changed.